Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Article in Clinical and Translational Radiation Oncology (December 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Clinical and Translational Radiation Oncology (December 2023)
Article in Journal of Neuro-Oncology (August 2023)
Article in Diagnostics (January 2023)